R69Q (p.Arg69Gln) variant of KRT4 (Keratin, type II cytoskeletal 4)

R69Q (p.Arg69Gln) in KRT4 (Keratin, type II cytoskeletal 4) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.21 / 1. The record also includes population frequency data and structural context.

R69Q (p.Arg69Gln) variant details